Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer
about
The Insulin/IGF System in Colorectal Cancer Development and Resistance to TherapyIGF-Binding Protein 2 - Oncogene or Tumor Suppressor?IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth?Linking patient outcome to high throughput protein expression data identifies novel regulators of colorectal adenocarcinoma aggressivenessProspectively isolated cancer-associated CD10(+) fibroblasts have stronger interactions with CD133(+) colon cancer cells than with CD133(-) cancer cells.Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741.Expression of insulin-like growth factor binding protein-2 in gastric carcinoma and its relationship with cell proliferation.Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites.Adiponectin: a link between obesity and cancer.IGF-II transgenic mice display increased aberrant colon crypt multiplicity and tumor volume after 1,2-dimethylhydrazine treatment.Blood-based protein biomarker panel for the detection of colorectal cancerDifferences in IGF-axis protein expression and survival among multiethnic breast cancer patients.The insulin-like growth factor system: towards clinical applications.Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patients.Elucidating the Activation Mechanism of the Insulin-Family Proteins with Molecular Dynamics Simulations.Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancer.Gene-gene, gene-environment & multiple interactions in colorectal cancer.Insulin-like growth factor binding protein 7 mediates glioma cell growth and migration.Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer.Insulin-like growth factor: current concepts and new developments in cancer therapy.Preoperative serum levels of insulin-like growth factor-binding protein 2 predict prognosis of gastric cancer patients.IGF-binding protein 2 is a candidate target of therapeutic potential in cancer.The development of composite circulating biomarker models for use in anticancer drug clinical development.Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells.Reciprocal relationship between expression of hypoxia inducible factor 1alpha (HIF-1alpha) and the pro-apoptotic protein bid in ex vivo colorectal cancer.Insulin-like growth factors and insulin-like growth factor-binding proteins in relation to disease status and incidence of hypoglycaemia in patients with a gastrointestinal stromal tumour.Current Tissue Molecular Markers in Colorectal Cancer: A Literature Review.Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.Prognostic relevance and performance characteristics of serum IGFBP-2 and PAPP-A in women with breast cancer: a long-term Danish cohort study.An Investigation of the Ligand Binding Properties and Negative Cooperativity of Soluble Insulin-like Growth Factor ReceptorsParadoxical elevations in serum IGF-II and IGF binding protein-2 in acromegaly: insights into the regulation of these peptides
P2860
Q26777125-36BDFAD1-F329-435D-A8CC-83C13FBAFD4DQ27003443-25B48D67-E730-4732-A683-54595D590002Q30320919-680E8B8E-56ED-46FB-A6B9-8A72F7A7044FQ30975797-92CAD2FB-7DB1-4FDF-80EA-C069121CB389Q33658808-B58493D3-A883-4B39-BB42-9D0D9E4C7703Q33791812-6036D273-5873-4846-AE9E-5F5D65DC72D0Q33869094-514514D6-1F88-4859-8F9B-FF03A03CECA2Q34418980-5C091898-E9A9-43E8-B3DE-92848F9BA585Q34549919-DBF6E955-917B-4D72-BE5F-2DD34FA026F7Q35165700-80793625-318E-43C8-A69E-C8B654744047Q35202822-2926AEE1-127E-4647-87E5-CA0367B22874Q35236778-7D205FBA-C532-4CF5-A8FA-6DF917094AA5Q35819252-8CBE5AAB-E3F2-4CCF-8372-7B18EE4141F4Q36105839-604A9D1D-C4FF-4132-80BD-1F524280E65EQ36109196-A8F8861C-0C03-41B9-8D64-6AE5382FD5CBQ36385291-273BE1F2-F3F6-42FE-9D99-110E3153F3EFQ36475800-8A0AB910-C4A9-4B9A-8978-330667FFE925Q36982095-738F3423-90FB-4A6E-A185-EA4DC7464A21Q37001399-565CAC1F-0864-4F8B-943F-1A0EBE375CFCQ37047067-F8C4FD9E-D5C6-4F4E-973E-DB417B18F997Q37706864-175AFD53-9A1F-4EF0-A166-B02F0D75CB42Q38667847-25B58D63-0448-4800-A0E7-5FF056DDA915Q39863702-C6154270-D7A3-482E-AE01-1D7CAF829748Q40259343-E36EBF30-B4E0-4355-B8DF-4F6B4477889BQ42424832-10E7CC39-47E4-4775-AB02-78E8B057BC19Q46093021-876564D3-69F2-45A4-957E-E37DC413772AQ47094355-DC352742-3CE7-4396-86C2-E4CB26DD52BDQ52598780-0ECDBC33-35C3-4B28-921A-660C6559DC31Q55418368-566895FB-B72A-47E8-A551-4A0007CF68D7Q58024148-ACA2D176-79B7-4E65-A7A4-BB025E67D483Q58887077-24D93231-F9AF-474C-A537-28F4BF742941
P2860
Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Elevated serum insulin-like gr ...... atients with colorectal cancer
@ast
Elevated serum insulin-like gr ...... atients with colorectal cancer
@en
type
label
Elevated serum insulin-like gr ...... atients with colorectal cancer
@ast
Elevated serum insulin-like gr ...... atients with colorectal cancer
@en
prefLabel
Elevated serum insulin-like gr ...... atients with colorectal cancer
@ast
Elevated serum insulin-like gr ...... atients with colorectal cancer
@en
P2093
P2860
P356
P1476
Elevated serum insulin-like gr ...... atients with colorectal cancer
@en
P2093
P2860
P2888
P304
P356
10.1054/BJOC.2000.1462
P407
P577
2000-11-01T00:00:00Z
P5875
P6179
1009954848